博瑞医药: 关于参加2025年半年度科创板创新药行业集体业绩说明会的公告

Group 1 - The company will hold a collective performance briefing for the innovative drug industry on September 16, 2025, from 15:00 to 17:00 [1][2] - The meeting will take place at the Shanghai Stock Exchange Roadshow Center, and it will be conducted in an online text interaction format [1][2] - Investors can submit questions from September 9, 2025, to September 15, 2025, before 16:00, through the Roadshow Center website or via the company's email [2][3] Group 2 - Key participants in the meeting will include the Chairman and General Manager Yuan Jiandong, Financial Director Zou Yuanlai, Independent Director Xu Dongdong, and Board Secretary Ding Nan [2] - After the briefing, investors can view the meeting's proceedings and main content on the Shanghai Stock Exchange Roadshow Center [3]